David Young
Founder at PROCESSA PHARMACEUTICALS, INC.
Net worth: 245 935 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ciaran Murray | M | 61 | 19 years | |
| Sian Bigora | M | 63 |
AGI Therapeutics Plc
 AGI Therapeutics Plc Pharmaceuticals: MajorHealth Technology AGI Therapeutics Plc provides pharmaceutical services. The firm engages in development and commercialization of differentiated drug products to treat unmet medical needs, including conditions which qualify for orphan drug status. The company was founded by John Devane and Patrick Ashe in 2003 and is headquartered in Dublin, Ireland. | 17 years |
| Simon Holmes | M | - | 19 years | |
| Justin Yorke | M | 58 | 7 years | |
| Patrick Lin | M | 58 | 13 years | |
| Wendy Guy | F | 59 | 15 years | |
| George Ng | M | 49 | 1 years | |
| Jim Stanker | M | 67 | 6 years | |
| Geraldine Pannu | F | 54 | 4 years | |
| Brendan Brennan | M | 45 | 18 years | |
| Mohammed Khoso Baluch | M | 66 | 2 years | |
| James Neal | M | 68 | 2 years | |
| Christopher Paul Blackwell | M | 62 |
AGI Therapeutics Plc
AGI Therapeutics Plc Pharmaceuticals: MajorHealth Technology AGI Therapeutics Plc provides pharmaceutical services. The firm engages in development and commercialization of differentiated drug products to treat unmet medical needs, including conditions which qualify for orphan drug status. The company was founded by John Devane and Patrick Ashe in 2003 and is headquartered in Dublin, Ireland. | 18 years |
| Mary Nyberg | F | - | - | |
| Smythe-Pinkerton Shanique | F | - | - | |
| Kayla Parks | F | - | - | |
| Weifei Ye | F | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Mulroy | M | 58 | 3 years | |
| Don Bailey | M | 78 | 8 years | |
| James Lawrence Fares | M | 61 | 2 years | |
| Bruce Given | M | 69 | 9 years | |
| Al Hansen | M | 69 | 3 years | |
| Virgil Thompson | M | 84 | 6 years | |
| Mitchell Blutt | M | 66 | - | |
| Stephen Farrell | M | 59 | 7 years | |
| Louis Silverman | M | 65 | 5 years | |
| Chang Rung Chen | M | - | 11 years | |
| Scott Whitcup | M | 64 | 2 years | |
| Steven C. Halladay | M | 76 | - | |
| Marilee Moy | F | 65 | - | |
| Aaron H. Burstein | M | - |
University of Maryland School of Pharmacy
| 4 years |
| Jason S. Zielonka | M | 75 | - | |
| Jon S. Kuwahara | M | 59 | 4 years | |
| Temi Oduozor | F | 46 | 3 years | |
| Darlene W. Romine | F | - | - | |
| Kwei-Hang Chan | M | 78 |
University of Maryland School of Pharmacy
| 13 years |
| R. Floyd | M | 68 | 3 years | |
| Gary S. Hogge | M | 56 | 3 years | |
| Raymond Furey | M | 56 | 3 years | |
| James Knight | M | - | 4 years | |
| Kirsten Fereday | F | - | - | |
| Kristine Engelke | F | 54 | - | |
| Howard D. Palefsky | M | - | - | |
| Eldon Mayer | M | 62 | - | |
| Timothy O'Neill | M | - | - | |
| Amir Shojaei | M | - |
AGI Therapeutics Plc
AGI Therapeutics Plc Pharmaceuticals: MajorHealth Technology AGI Therapeutics Plc provides pharmaceutical services. The firm engages in development and commercialization of differentiated drug products to treat unmet medical needs, including conditions which qualify for orphan drug status. The company was founded by John Devane and Patrick Ashe in 2003 and is headquartered in Dublin, Ireland. | 2 years |
| Michael Aldridge | M | 57 | 2 years | |
| Khalid Islam | M | 67 | 2 years | |
| George M. Stuart | M | 61 | 3 years | |
| George Martin | M | 65 | 1 years | |
| Angus Russell | M | 68 | 1 years | |
| Jon Saxe | M | 88 | 7 years | |
| Robert Rubin | M | 78 | - | |
| Gary M. Sawka | M | 77 | 2 years | |
| Eric J. Liebler | M | 60 | 1 years | |
| Gregg Lapointe | M | 65 | 2 years | |
| Craig Charles Chambliss | M | - | 2 years | |
| Peter Franks | M | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 52 | 89.66% |
| Ireland | 7 | 12.07% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David Young
- Personal Network
